Operator
Good afternoon, and welcome to Fortress Biosciences’ Third Quarter 2025 Convention Name. As a reminder, at the moment’s name is being recorded.
[Operator Instructions] I wish to flip the decision over to Camilla Zuckero, Vice President, Investor Relations and Company Affairs. Please go forward.
Camilla Zuckero
Vice President of Investor Relations & Company Affairs
Thanks, operator. Good afternoon, everybody. Welcome to Fortress Biosciences’ Third Quarter 2025 Outcomes Convention Name. Becoming a member of me at the moment are Fortress’s Founder, President and Chief Government Officer, Derek Maetzold; Chief Monetary Officer, Frank Stokes; and Senior Vice President, Medical, Dr. Matthew Goldberg, Board-certified dermatologist and dermatopathologist.
Info recorded on this name speaks solely as of at the moment, November 3, 2025. Subsequently, if you’re listening to the replay or studying the transcript of this name, any time-sensitive info might not be correct. A recording of at the moment’s name will probably be out there on the Investor Relations web page of the corporate’s web site for roughly 3 weeks following the conclusion of the decision.
Earlier than we start, I wish to remind you that among the statements made at the moment will include forward-looking statements, together with statements about anticipated addressable market, statements containing projections relating to future occasions or our future monetary or operational outcomes and efficiency, together with our anticipated 2025 whole income and the influence
